Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q3 2025 Earnings Call Transcript October 30, 2025
Phathom Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.15, expectations were $-0.3.
Operator: Hello, and welcome to the Phathom Pharmaceuticals’ Third Quarter 2025 Earnings Results Call. [Operator Instructions] Please be advised that today’s call is being recorded. With that, I would like to turn the call over to Eric Sciorilli, Phathom’s Head of Investor Relations. Please go...
